{"id":"https://openalex.org/W2561399185","doi":null,"title":"INTERNATIONAL JOURNAL OF PHARMACY & LIFE SCIENCES (Int. J. of Pharm. Life Sci.) Alzheimer's disease Inhibitors: Current status and future prospects","display_name":"INTERNATIONAL JOURNAL OF PHARMACY & LIFE SCIENCES (Int. J. of Pharm. Life Sci.) Alzheimer's disease Inhibitors: Current status and future prospects","publication_year":2014,"publication_date":"2014-01-01","ids":{"openalex":"https://openalex.org/W2561399185","mag":"2561399185"},"language":"en","primary_location":{"id":"pmh:oai:ojs2.ijplsjournal.com:article/530","doi":null,"is_oa":true,"landing_page_url":"https://ijplsjournal.com/index.php/ijpls/article/view/530","pdf_url":"https://ijplsjournal.com/index.php/ijpls/article/download/530/506","source":{"id":"https://openalex.org/S5407055365","display_name":"International Journal of Pharmacy and Life Sciences","issn_l":"0976-7126","issn":["0976-7126"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"0976-7126","raw_type":"info:eu-repo/semantics/article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://ijplsjournal.com/index.php/ijpls/article/download/530/506","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103162149","display_name":"Ankit Singh","orcid":"https://orcid.org/0000-0001-9896-047X","observed_orcids":["https://orcid.org/0000-0001-9896-047X"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Ankit Singh","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5103162149"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.9726999998092651,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.9726999998092651,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.026900000870227814,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.9909999966621399},{"id":"https://openalex.org/keywords/acetylcholinesterase-inhibitors","display_name":"acetylcholinesterase inhibitors","score":0.9959999918937683},{"id":"https://openalex.org/keywords/monoamine-oxidase-inhibitors","display_name":"monoamine oxidase inhibitors","score":0.9190000295639038},{"id":"https://openalex.org/keywords/nmda-receptor-antagonist","display_name":"NMDA receptor antagonists","score":0.878000020980835},{"id":"https://openalex.org/keywords/amyloid-beta","display_name":"amyloid-beta","score":0.6259999871253967},{"id":"https://openalex.org/keywords/tau-aggregation","display_name":"tau aggregation","score":0.7799999713897705},{"id":"https://openalex.org/keywords/amyloid-plaques","display_name":"amyloid plaques","score":0.8519999980926514},{"id":"https://openalex.org/keywords/presenilin-1","display_name":"presenilin 1","score":0.796999990940094},{"id":"https://openalex.org/keywords/apolipoprotein-e","display_name":"apolipoprotein E","score":0.8560000061988831},{"id":"https://openalex.org/keywords/amyloid-precursor-protein","display_name":"amyloid precursor protein","score":0.921999990940094},{"id":"https://openalex.org/keywords/rivastigmine","display_name":"rivastigmine","score":0.7870000004768372},{"id":"https://openalex.org/keywords/antioxidants","display_name":"antioxidants","score":0.5149999856948853},{"id":"https://openalex.org/keywords/metal-chelators","display_name":"metal chelators","score":0.9409999847412109},{"id":"https://openalex.org/keywords/acetylcholine","display_name":"acetylcholine","score":0.5899999737739563},{"id":"https://openalex.org/keywords/drug-design","display_name":"drug design","score":0.32499998807907104}],"concepts":[{"id":"https://openalex.org/C2778816929","wikidata":"https://www.wikidata.org/wiki/Q22676679","display_name":"Acetylcholinesterase","level":3,"score":0.6324043273925781},{"id":"https://openalex.org/C175344181","wikidata":"https://www.wikidata.org/wiki/Q907198","display_name":"Presenilin","level":4,"score":0.6206314563751221},{"id":"https://openalex.org/C2776332859","wikidata":"https://www.wikidata.org/wiki/Q411887","display_name":"Rivastigmine","level":5,"score":0.5921266078948975},{"id":"https://openalex.org/C2780904820","wikidata":"https://www.wikidata.org/wiki/Q415081","display_name":"Donepezil","level":4,"score":0.5340026617050171},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5249131917953491},{"id":"https://openalex.org/C2776024655","wikidata":"https://www.wikidata.org/wiki/Q410867","display_name":"Monoamine oxidase","level":3,"score":0.5138140320777893},{"id":"https://openalex.org/C57089818","wikidata":"https://www.wikidata.org/wiki/Q424728","display_name":"Apolipoprotein E","level":3,"score":0.5005311965942383},{"id":"https://openalex.org/C68026918","wikidata":"https://www.wikidata.org/wiki/Q1970256","display_name":"Senile plaques","level":4,"score":0.47796177864074707},{"id":"https://openalex.org/C2777633098","wikidata":"https://www.wikidata.org/wiki/Q2736051","display_name":"Amyloid (mycology)","level":2,"score":0.4269286096096039},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3673516511917114},{"id":"https://openalex.org/C502032728","wikidata":"https://www.wikidata.org/wiki/Q11081","display_name":"Alzheimer's disease","level":3,"score":0.3439967632293701},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3426259160041809},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.3132363259792328},{"id":"https://openalex.org/C2779483572","wikidata":"https://www.wikidata.org/wiki/Q83030","display_name":"Dementia","level":3,"score":0.2888595461845398},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.27051013708114624},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2561420202255249},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.14077094197273254},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.11949402093887329}],"mesh":[],"locations_count":2,"locations":[{"id":"pmh:oai:ojs2.ijplsjournal.com:article/530","doi":null,"is_oa":true,"landing_page_url":"https://ijplsjournal.com/index.php/ijpls/article/view/530","pdf_url":"https://ijplsjournal.com/index.php/ijpls/article/download/530/506","source":{"id":"https://openalex.org/S5407055365","display_name":"International Journal of Pharmacy and Life Sciences","issn_l":"0976-7126","issn":["0976-7126"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"0976-7126","raw_type":"info:eu-repo/semantics/article"},{"id":"mag:2561399185","doi":null,"is_oa":false,"landing_page_url":"http://www.ijplsjournal.com/issues%20PDF%20files/2014/August-2014/5.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":{"id":"pmh:oai:ojs2.ijplsjournal.com:article/530","doi":null,"is_oa":true,"landing_page_url":"https://ijplsjournal.com/index.php/ijpls/article/view/530","pdf_url":"https://ijplsjournal.com/index.php/ijpls/article/download/530/506","source":{"id":"https://openalex.org/S5407055365","display_name":"International Journal of Pharmacy and Life Sciences","issn_l":"0976-7126","issn":["0976-7126"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"0976-7126","raw_type":"info:eu-repo/semantics/article"},"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2561399185.pdf","grobid_xml":"https://content.openalex.org/works/W2561399185.grobid-xml"},"referenced_works_count":14,"referenced_works":["https://openalex.org/W1541218967","https://openalex.org/W1548350282","https://openalex.org/W1558835554","https://openalex.org/W1983127584","https://openalex.org/W1991124307","https://openalex.org/W1996223952","https://openalex.org/W2001580341","https://openalex.org/W2005353089","https://openalex.org/W2032113087","https://openalex.org/W2075927469","https://openalex.org/W2090777700","https://openalex.org/W2097802864","https://openalex.org/W2132069490","https://openalex.org/W2187157853"],"related_works":["https://openalex.org/W7216911835","https://openalex.org/W2063268875","https://openalex.org/W3135772303","https://openalex.org/W4297920714","https://openalex.org/W2402490795","https://openalex.org/W2047420624","https://openalex.org/W2317583919","https://openalex.org/W2047682358","https://openalex.org/W4384828103","https://openalex.org/W2899012683"],"abstract_inverted_index":{"Alzheimer":[0,211,248],"disease":[1,33,249],"is":[2,12,29,35,54,197,201,205],"a":[3,69,183,198,257,261],"major":[4],"public":[5],"health":[6],"problem":[7],"in":[8,50,108,151,208,238],"the":[9,13,20,51,58,66,98,109,127,159,166,174,179],"elderly.":[10],"It":[11,28,53,213],"most":[14],"predominant,":[15],"intricate":[16],"neurodegenerative":[17],"disorder":[18],"of":[19,48,72,104,111,153,161,165,210,244,264],"brain,":[21],"affecting":[22],"above":[23],"20":[24],"million":[25],"individuals":[26],"global.":[27],"an":[30],"insanity":[31],"related":[32],"which":[34,200],"characterized":[36],"by":[37,101,163,181,203],"t-protein":[38],"aggregation,":[39],"amyloid-":[40],"\u03b2":[41],"pledges,":[42],"oxidative":[43],"stress":[44],"and":[45,60,87,91,144,170,177,186,221,233,246,255],"lowered":[46],"levels":[47],"acetylcholine":[49,105],"brain.":[52],"also":[55],"believed":[56],"that":[57,122],"plaques":[59,162,176],"tangles":[61],"are":[62,251],"mainly":[63],"responsible":[64],"for":[65,260],"disease.":[67,129,212],"Presently":[68],"few":[70],"class":[71],"drugs":[73,86],"such":[74],"as":[75,189],"antioxidants,":[76],"metal":[77],"chelators,":[78],"acetylcholinesterase":[79,95],"(AChE)":[80],"inhibitors,":[81,84],"monoamine":[82],"oxidase":[83],"anti-provocative":[85],"NMDA":[88],"inhibitors":[89,96,191,250],"present":[90],"offer":[92,256],"relief.":[93],"Presently,":[94],"improve":[97],"neurological":[99],"behaviour":[100],"increasing":[102],"availability":[103],"at":[106],"synapse":[107],"presence":[110],"intact":[112],"cholinergic":[113],"neurons.":[114],"The":[115,242],"genetic":[116],"studies":[117],"have":[118,214],"revealed":[119],"four":[120,131,154],"genes":[121,132,155],"may":[123],"be":[124],"linked":[125],"to":[126,158,172,192,240],"Alzheimer\u2019s":[128],"These":[130],"include:":[133],"amyloid":[134,167,175],"precursor":[135],"protein":[136],"(APP),":[137],"presenilin":[138,141],"1":[139],"(PS1),":[140],"2":[142],"(PS2)":[143],"apolipoprotein":[145],"E":[146],"(ApoE).":[147],"When":[148],"mutation":[149],"occur":[150],"anyone":[152],"its":[156],"lead":[157],"formation":[160],"production":[164],"beta":[168],"40":[169],"42.Ways":[171],"reduce":[173],"inhibit":[178],"action":[180],"constructing":[182],"drug":[184,199],"(1E,4Z,6E)-5-hydroxy-7-(3-hydroxyphenyl)-1-(2-methyl-3,4,4a,8a-tetrahydro-2H-1-benzopyran-8-yl)hepta-1,4,6-trien-3-one":[185],"noname":[187],"3":[188],"potent":[190],"PSEN-1":[193],"binding":[194,226,231],"domain":[195],"(aa440).Rivastigmine":[196],"approved":[202],"FDI":[204],"mostly":[206],"used":[207],"treatment":[209],"only":[215],"two":[216],"analogues:":[217],"MOL-":[218],"I":[219],"(R=OH)":[220],"MOL-III":[222],"(R=Br)":[223],"showed":[224],"good":[225],"energies,":[227],"low":[228],"relative":[229],"free":[230],"energy":[232],"high":[234],"affinities":[235],"towards":[236],"AChE":[237],"comparison":[239],"Rivastigmine.":[241],"benefits":[243],"specific":[245],"selective":[247],"currently":[252],"under":[253],"discussion":[254],"new":[258],"perspective":[259],"further":[262],"development":[263],"inhibitors.":[265]},"counts_by_year":[],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2017-01-06T00:00:00"}
